mRNA |
piperlongumine:MST-312 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.065 |
0.07 |
mRNA |
ABT-888 |
CTRPv2 |
pan-cancer |
AAC |
0.067 |
0.07 |
mRNA |
Zebularine |
CTRPv2 |
pan-cancer |
AAC |
0.062 |
0.07 |
mRNA |
MS-275 |
CTRPv2 |
pan-cancer |
AAC |
-0.059 |
0.08 |
mRNA |
MLN2238 |
CTRPv2 |
pan-cancer |
AAC |
-0.062 |
0.08 |
mRNA |
Bortezomib |
CTRPv2 |
pan-cancer |
AAC |
-0.063 |
0.08 |
mRNA |
Tamoxifen |
CTRPv2 |
pan-cancer |
AAC |
0.067 |
0.08 |
mRNA |
triazolothiadiazine |
CTRPv2 |
pan-cancer |
AAC |
-0.053 |
0.08 |
mRNA |
tigecycline |
CTRPv2 |
pan-cancer |
AAC |
-0.092 |
0.09 |
mRNA |
selumetinib:PLX-4032 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.061 |
0.09 |